Published Date: 08 Mar 2023
Hospitals in New Mexico, Texas and Oklahoma are the first to call for a new rural hospital payment model that shifts services from inpatients to outpatients and emergency patients.
Read Full NewsA prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, you may be faced with multiple treatment options and asked to make a choice—surgery, radiation ...
Neuroblastoma remains one of the deadliest childhood malignancies, accounting for a disproportionate number of pediatric cancer deaths worldwide.
1.
In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.
2.
FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.
3.
Glioblastoma treatment breakthrough shows promise
4.
Hair Growth After Cancer; 'Global' Early-Onset CRC; Retifanlimab Boosts OS in NSCLC
5.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
1.
Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
4.
Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact
5.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Updates on the First Line Management of ALK+ NSCLC
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation